Company / Revenue
BIODESIX INC Revenue History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$88.5M
FY2025
5-year range
$38.2M / $88.5M
FY2021-FY2025
Trend
+24.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Revenue has increased for 3 consecutive years, from $38M in FY2022 to $88M in FY2025.
Based on SEC 10-K filings.
$88M in FY2025 with a 5-year CAGR of +14.2%.
Improved from $49M to $88M over the past 2 years.
Revenue over time
Growth rates
- 3-Year CAGR
- +32.3%
- 5-Year CAGR
- +14.2%
- 10-Year CAGR
- -
Key checks
Key Insights
- BIODESIX INC's revenue has grown for 3 consecutive years.
- 5-year CAGR of +14.2%, indicating consistent growth.
- In FY2025, revenue increased 24.1% year-over-year.
- Lowest revenue in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score -4.69 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $88.5M | +24.1% |
| FY2024 | $71.3M | +45.3% |
| FY2023 | $49.1M | +28.5% |
| FY2022 | $38.2M | -29.9% |
| FY2021 | $54.5M | +19.6% |
| FY2020 | $45.6M | - |
As of FY2025 · SEC Form 10-K · Last checked Jun 21, 2026